Health-related quality of life decline in clinically stable inflammatory bowel disease patients during the COVID-19 outbreak
- 1 January 2022
- journal article
- research article
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 115 (6) , 315-319
Abstract
Background and aims: inflammatory bowel disease (IBD) affects many aspects of a patient's life and impairs their health-related quality of life (HRQoL). The COVID-19 out-break has led to important mobility restrictions and a dra-matic re-adjustment of social habits and health systems. This study aimed to assess the influence of the outbreak and mo-bility restrictions on the HRQoL of IBD patients with stable clinical remission on biologic treatment. Their self-perceived stress scores during the outbreak were also assessed. Methods: a prospective, observational study was performed in IBD patients on biologic treatment with stable clinical re-mission. Patients with both Crohn's disease (CD) and ulcerati-ve colitis (UC)were included. Patients filled in the IBDQ9 and the Perceived Stress Scale (PSS) electronically. To determine any changes, the results of the IBDQ9 during the outbreak were compared with the last IBDQ9 before the outbreak. Results: one hundred and six patients in clinical remission were included, with a median age of 42 years; 42 % were female and 77 % had CD. Median pre-COVID-19 IBDQ9 was 72.1 (66.5-80.12) and decreased to 69.2 (63.1-77.10) during the outbreak (p < 0.001). The median PSS score was 12 (9-19). There was a significant negative correlation between the PSS and the outbreak IBDQ9 (r =-0.66, p < 0.001). Re-gression analysis showed that the PSS score was associated with a lower IBDQ9 during the outbreak (p < 0.001). Conclusion: there was a negative impact of the COVID-19 outbreak on the HRQoL of IBD patients in remission, with higher self-perceived stress scores associated with a lower QoL. The COVID-19 outbreak may have long-term implica- tions for the HRQoL in these patients.Keywords
This publication has 18 references indexed in Scilit:
- AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert CommentaryGastroenterology, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Consequences and management of COVID-19 on the care activity of an inflammatory Bowel Disease unit.Revista Española de Enfermedades Digestivas, 2020
- Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatientsRevista Española de Enfermedades Digestivas, 2020
- Normalization of long-term quality of life in Crohn s disease patients receiving ustekinumabRevista Española de Enfermedades Digestivas, 2020
- Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agentsJournal of Gastroenterology and Hepatology, 2015
- Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a normal health related quality of lifeJournal of Crohn's and Colitis, 2010
- Sustained improvement of health-related quality of life in Crohnʼs disease patients treated with infliximab and azathioprine for 4 yearsInflammatory Bowel Diseases, 2007
- Assessment of the Influence of Disease Activity on the Quality of Life of Patients with Inflammatory Bowel Disease Using a Short QuestionnaireAmerican Journal of Gastroenterology, 2004